Biotech entity
pharma is the sole category represented across all 1 tracked stories. Netflix is most often covered alongside Antibiotics, which appears in 1 of these 1 story. At 7, the average consequence score sits above the same-window beat average of 6.
Last mentioned: Aug 16, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Netflix is most often covered alongside Antibiotics, which appears in 1 of these 1 story. At 7, the average consequence score sits above the same-window beat average of 6. Source depth averages 3 original sources per story, versus 2.4 across the same-window beat baseline. Netflix appears in 1 tracked Biotech story from February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Netflix. Shared-story counts are live from our verified record — not editorial picks.
Experts are calling for a radical shift in antibiotic procurement, moving toward a subscription-based 'Netflix model' to incentivize the development of new drugs against resistant superbugs. This approach aims to decouple pharmaceutical revenue from sales volume, ensuring a steady supply of critical treatments as antimicrobial resistance escalates globally.
Netflix is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
